Finally, although the results of this meta-analysis suggested that pre-treatment AFP-L3% may have significant prognostic value in HCC patients with low AFP concentration, the external validity of results and applicability requires more studies to be done, because only two studies assessed the prognostic value of AFP-L3% in HCC with low AFP concentration in our meta-analysis. This evidence concerns the gene AFP and hepatocellular carcinoma.